We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SOUN:NASDAQSoundHound AI, Inc. Analysis

Data as of 2026-09-06 - not real-time

$6.74

Latest Price

9/10Risk

Risk Level: High

Executive Summary

At $6.74, SoundHound AI, Inc. shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it gained 9.4%. Momentum indicators put RSI at 45.4 (neutral) with MACD reading bearish. Recent trading has carved out support near $6.61 and resistance around $7.94.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 88.6% above where the shares trade now. Revenue is growing at 45.0% on a -67.5% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 73.7%, a beta of 3.08 and a maximum drawdown of 73.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — sell in the near term, hold further out, at 3/10 long-term conviction.

Top Market Events

SoundHound AI closes its LivePerson acquisition, targeting over $500M in future revenue while expanding enterprise AI...Yahoo Finance1monSoundHound AI Inc SOUN Q2 2026 Earnings Call Highlights: Record Revenue and Strategic MomentumThe...SoundHound AI stock has lost roughly 40% of its value so far this year.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Trading below the 200-day average of 8.34
  • MACD momentum is negative
  • 30-day price change of +9.4%

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Trading below the 200-day average of 8.34
  • Analyst targets imply +88.6% versus the current price
  • 30-day volatility of 73.7%

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Negative profit margin of -67.5%
  • Analyst targets imply +88.6% versus the current price
  • Negative return on equity of -32.2%

Key Metrics & Analysis

Financial Health

Revenue Growth45.00%
Profit Margin-67.45%
P/E Ratio-45.7
ROE-32.24%
ROA-19.47%
Debt/Equity1.11
P/B Ratio6.0
Op. Cash Flow$-114509000
Free Cash Flow$-45495500
Industry P/E33.2

Technical Analysis

TrendNeutral
RSI45.4
Support$6.61
Resistance$7.94
MA 20$7.12
MA 50$6.75
MA 200$8.34
MACDBearish
VolumeDecreasing
Fear & Greed Index95.48

Valuation

Target Price$12.71
Upside/Downside88.64%
GradeFair
TypeGrowth

Risk Assessment

Beta3.08
Volatility73.65%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.